Other Treatment
Bleeding problems caused by
hemophilia can be prevented and treated with clotting
factor replacement therapy.
Clotting factors come from blood donors (plasma-derived clotting factors) or are produced in a
laboratory (recombinant or
DNA-engineered). The amount of clotting factor needed
is determined by how severe the hemophilia is and/or the location of the
bleeding. More clotting factor is needed for surgery or bleeding in the brain
than for less serious situations, such as routine dental procedures.
Depending upon how severe your disease is, you may choose either
to:
- Receive regularly scheduled infusions of
clotting factor to prevent bleeding.
- Receive clotting factor on
demand, that is, only after bleeding starts or before you participate in an
activity that will likely cause bleeding.
Should I have regularly scheduled or on-demand
clotting factor replacement therapy for hemophilia?
Sometimes a person's body develops antibodies—called
inhibitors—to the injected clotting factor. People who
have severe hemophilia or who receive clotting factor replacement for the first
time are more likely to develop inhibitors, as are children. When this occurs,
specially engineered replacement clotting factors may be required. Other
treatment for clotting factor inhibitors includes therapy to suppress the
immune system (immunosuppressive therapy).
Other Treatment Choices
- Clotting factor
replacement
- Treatment for people who have
inhibitors
What To Think About
Gene therapy may eventually be able to boost the body's ability
to make clotting factor. Researchers have developed genes that can cause a
person to make clotting factors (for example, factor VIII). These genes have
been transplanted into people with hemophilia in research studies. But the
people could only produce a very low level of factor VIII. And the clotting
factor lasted for less than a year. But no serious side effects were seen. Gene
therapy is still a promising treatment for hemophilia, and research is
ongoing.4